Agios Pharmaceuticals AGIO
$ 35.39
-1.17%
Quarterly report 2024-Q3
added 10-31-2024
Agios Pharmaceuticals Balance Sheet 2011-2024 | AGIO
Annual Balance Sheet Agios Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-16.2 M | -53.6 M | -192 M | -127 M | 32.7 M | -70.5 M | -103 M | -161 M | -71.8 M | -14 M | -71.6 M | -91.3 M | -118 M |
Long Term Debt |
57 M | 72 M | 276 K | 164 K | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
15 M | 13.7 M | 10.8 M | 7.09 M | 6.64 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 157 M | 77.4 M | 144 M | 172 M | 22.1 M | 6.45 M | 32.8 M | 58 M | 83.2 M |
Total Current Liabilities |
68 M | 62.6 M | 59.8 M | 94.4 M | 92.9 M | 93.5 M | 94.9 M | 88.4 M | 52.9 M | 61.1 M | 36.9 M | - | - |
Total Liabilities |
126 M | 138 M | 146 M | 453 M | 250 M | 171 M | 239 M | 261 M | 74.9 M | 67.5 M | 69.7 M | 93.1 M | 131 M |
Deferred Revenue |
- | - | - | - | 10.9 M | 32.7 M | 37.8 M | 35.9 M | 19.7 M | 35.7 M | 25.1 M | 25.1 M | 25.1 M |
Retained Earnings |
-823 M | -471 M | -239 M | -1.84 B | -1.52 B | -1.1 B | -798 M | -483 M | -285 M | -167 M | -113 M | -74 M | -53.9 M |
Total Assets |
937 M | 1.24 B | 1.44 B | 853 M | 891 M | 858 M | 614 M | 619 M | 420 M | 492 M | 201 M | 137 M | 194 M |
Cash and Cash Equivalents |
88.2 M | 139 M | 203 M | 127 M | 80.9 M | 70.5 M | 103 M | 161 M | 71.8 M | 14 M | 71.6 M | 91.3 M | 118 M |
Book Value |
811 M | 1.1 B | 1.29 B | 400 M | 641 M | 688 M | 376 M | 359 M | 345 M | 424 M | 131 M | 43.9 M | 63.1 M |
Total Shareholders Equity |
811 M | 1.1 B | 1.29 B | 400 M | 641 M | 688 M | 376 M | 359 M | 345 M | 424 M | 131 M | -72 M | -52.8 M |
All numbers in USD currency
Quarterly Balance Sheet Agios Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
44.5 M | 48.8 M | 52.9 M | 57 M | 60.8 M | 64.6 M | 68.3 M | 72 M | 75.5 M | - | 276 K | 85.7 M | - | 167 K | 248 K | 331 K | 331 K | 331 K | 331 K | 673 K | 673 K | 106 M | 106 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
165 M | 113 M | 106 M | 126 M | 120 M | 121 M | 115 M | 138 M | 130 M | - | 128 M | 146 M | 147 M | 153 M | 192 M | 453 M | 453 M | 453 M | 453 M | 250 M | 250 M | 250 M | 250 M | 171 M | 171 M | 171 M | 171 M | 239 M | 239 M | 239 M | 239 M | 261 M | 261 M | 261 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | 2.5 M | - | - | - | - | - | - | - | 4.75 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M | 32.7 M | 32.7 M | 41.1 M | 39.2 M | 37.8 M | 35.9 M | 37.1 M | 37.8 M | 35.9 M | 35.9 M | 35.9 M | 35.9 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 35.7 M | 35.7 M | 35.7 M | 35.7 M | 25.1 M | 25.1 M | 25.1 M | 25.1 M | 25.1 M | 25.1 M | 25.1 M | - | - | - | - | - |
Retained Earnings |
-52.4 M | -1 B | -904 M | -823 M | -727 M | -635 M | -552 M | -471 M | -507 M | - | -334 M | -239 M | -144 M | -55.4 M | 30.8 M | -1.84 B | -1.84 B | -1.84 B | -1.84 B | -1.52 B | -1.52 B | -1.52 B | -1.52 B | -1.1 B | -1.1 B | -1.1 B | -1.1 B | -798 M | -798 M | -798 M | -798 M | -483 M | -483 M | -483 M | -483 M | -285 M | -285 M | -285 M | -285 M | -167 M | -167 M | -167 M | -167 M | -113 M | -113 M | -113 M | -113 M | -74 M | -74 M | -74 M | - | - | - | - | - |
Total Assets |
1.79 B | 773 M | 850 M | 937 M | 1.01 B | 1.09 B | 1.15 B | 1.24 B | 1.18 B | - | 1.34 B | 1.44 B | 1.54 B | 1.87 B | 2.49 B | 853 M | 853 M | 853 M | 853 M | 891 M | 891 M | 891 M | 891 M | 858 M | 858 M | 858 M | 858 M | 614 M | 614 M | 614 M | 614 M | 619 M | 619 M | 619 M | 619 M | 420 M | 420 M | 420 M | 420 M | 492 M | 492 M | 492 M | 492 M | 201 M | 201 M | 201 M | 201 M | 137 M | 137 M | 137 M | - | - | - | - | - |
Cash and Cash Equivalents |
254 M | 84.5 M | 119 M | 88.2 M | 64.3 M | 84.8 M | 104 M | 139 M | 122 M | 88.5 M | 80 M | 203 M | 400 M | 969 M | 1.89 B | 127 M | 127 M | 127 M | 127 M | 80.9 M | 80.9 M | 80.9 M | 80.9 M | 70.5 M | 70.5 M | 70.5 M | 70.5 M | 103 M | 103 M | 103 M | 103 M | 161 M | 161 M | 161 M | 161 M | 71.8 M | 71.8 M | 71.8 M | 71.8 M | 14 M | 14 M | 14 M | 14 M | 71.6 M | 71.6 M | 71.6 M | 71.6 M | 91.3 M | 91.3 M | 91.3 M | - | 118 M | - | - | - |
Book Value |
1.63 B | 661 M | 744 M | 811 M | 887 M | 964 M | 1.04 B | 1.1 B | 1.05 B | - | 1.21 B | 1.29 B | 1.39 B | 1.72 B | 2.3 B | 400 M | 400 M | 400 M | 400 M | 641 M | 641 M | 641 M | 641 M | 688 M | 688 M | 688 M | 688 M | 376 M | 376 M | 376 M | 376 M | 359 M | 359 M | 359 M | 619 M | 420 M | 420 M | 420 M | 420 M | 492 M | 492 M | 492 M | 492 M | 201 M | 201 M | 201 M | 201 M | 137 M | 137 M | 137 M | - | - | - | - | - |
Total Shareholders Equity |
1.63 B | 661 M | 744 M | 811 M | 887 M | 964 M | 1.04 B | 1.1 B | 1.05 B | 1.12 B | 1.21 B | 1.29 B | 1.39 B | 1.72 B | 2.3 B | 400 M | 400 M | 400 M | 400 M | 641 M | 641 M | 641 M | 641 M | 688 M | 688 M | 688 M | 688 M | 376 M | 376 M | 376 M | 376 M | 359 M | 359 M | 359 M | 359 M | 345 M | 345 M | 345 M | 345 M | 424 M | 424 M | 424 M | 424 M | 131 M | 131 M | 131 M | 131 M | -72 M | -72 M | -72 M | - | -52.8 M | - | - | - |
All numbers in USD currency